In this episode, we explore the cardiac and metabolic safety profile of antipsychotics in youth, based on a World Health Organization Safety Database analysis. We discuss age-dependent risks, specific medication concerns, and the importance of monitoring. How can clinicians balance the benefits of antipsychotics with potential cardiometabolic risks in young patients?
Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D.
Psychopharmacology and Psychiatry Updates